189 related articles for article (PubMed ID: 1548523)
1. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
[TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
[TBL] [Abstract][Full Text] [Related]
4. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
[TBL] [Abstract][Full Text] [Related]
5. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
[TBL] [Abstract][Full Text] [Related]
6. Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group study.
Harris MB; Shuster JJ; Carroll A; Look AT; Borowitz MJ; Crist WM; Nitschke R; Pullen J; Steuber CP; Land VJ
Blood; 1992 Jun; 79(12):3316-24. PubMed ID: 1596572
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
[TBL] [Abstract][Full Text] [Related]
8. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Smith M; Arthur D; Camitta B; Carroll AJ; Crist W; Gaynon P; Gelber R; Heerema N; Korn EL; Link M; Murphy S; Pui CH; Pullen J; Reamon G; Sallan SE; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
J Clin Oncol; 1996 Jan; 14(1):18-24. PubMed ID: 8558195
[TBL] [Abstract][Full Text] [Related]
9. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
10. Pilot studies of species-specific chemotherapy of childhood acute lymphoblastic leukemia using genotype and immunophenotype.
Manera R; Ramirez I; Mullins J; Pinkel D
Leukemia; 2000 Aug; 14(8):1354-61. PubMed ID: 10942229
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Shuster JJ; Falletta JM; Pullen DJ; Crist WM; Humphrey GB; Dowell BL; Wharam MD; Borowitz M
Blood; 1990 Jan; 75(1):166-73. PubMed ID: 1688495
[TBL] [Abstract][Full Text] [Related]
12. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
[TBL] [Abstract][Full Text] [Related]
13. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
[TBL] [Abstract][Full Text] [Related]
14. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic implication of DNA contents on long-term outcome of childhood acute lymphoblastic leukemia].
Tsurusawa M; Katano N; Aoyama M; Fujimoto T; Nishikawa K; Hatae Y; Miyake M; Kawakami K; Furuyama T; Iwai A; Horikoshi Y
Rinsho Ketsueki; 1997 Jul; 38(7):561-5. PubMed ID: 9267157
[TBL] [Abstract][Full Text] [Related]
16. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
Pullen J; Shuster JJ; Link M; Borowitz M; Amylon M; Carroll AJ; Land V; Look AT; McIntyre B; Camitta B
Leukemia; 1999 Nov; 13(11):1696-707. PubMed ID: 10557041
[TBL] [Abstract][Full Text] [Related]
17. Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
Toyoda Y; Manabe A; Tsuchida M; Hanada R; Ikuta K; Okimoto Y; Ohara A; Ohkawa Y; Mori T; Ishimoto K; Sato T; Kaneko T; Maeda M; Koike Ki; Shitara T; Hoshi Y; Hosoya R; Tsunematsu Y; Bessho F; Nakazawa S; Saito T
J Clin Oncol; 2000 Apr; 18(7):1508-16. PubMed ID: 10735899
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
Liang DC; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Peng CT; Lin MT; Chang TK; Jaing TH; Liu HC; Wang LY; Yeh TC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Wu KH; Hung GY; Chen RL; Chen SH; Cheng SN; Chang YH; Chen BW; Ho WL; Wang JL; Lin ST; Hsieh YL; Wang SC; Chang HH; Yang YL; Huang FL; Chang CY; Chang WH; Lin KS
Leukemia; 2010 Feb; 24(2):397-405. PubMed ID: 20016538
[TBL] [Abstract][Full Text] [Related]
19. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia.
Look AT; Roberson PK; Williams DL; Rivera G; Bowman WP; Pui CH; Ochs J; Abromowitch M; Kalwinsky D; Dahl GV
Blood; 1985 May; 65(5):1079-86. PubMed ID: 3158360
[TBL] [Abstract][Full Text] [Related]
20. Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X.
Pui CH; Dodge RK; Look AT; George SL; Rivera GK; Abromowitch M; Ochs J; Evans WE; Crist WM; Simone JV
J Clin Oncol; 1991 Aug; 9(8):1341-7. PubMed ID: 2072137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]